FDA Approves Tocilizumab for GCA

May 24, 2017

Tocilizumab in its subcutaneous form is the first-ever drug designated for giant cell arteritis which affects 230,000 people in the U.S

Diagnosing and Treating Vasculitis: an Update

April 13, 2017

Mayo Clinic’s Dr. Eric Matteson and Dr. Sharon Chung of UCSF provide an update on advances in new treatments for vasculitis.

Efficacy of Abatacept for Treating Vasculitis

March 13, 2017

Two new studies find that abatacept plus prednisone improves duration of remission for giant cell arteritis patients, but not for Takayasu’s arteritis patients.

Gastrointestinal Involvement in Systemic Vasculitis

October 10, 2016

Gastrointestinal involvement is known to be associated with primary vasculitis. But in some cases, it may be IBD with secondary vasculitis, this review shows.

EULAR Updates Vasculitis Treatment Recommendations

July 05, 2016

The European League Against Rheumatism has updated its 2009 recommendations for the management of antineutrophil cytoplasmic antibody-associated vasculitis.

IM Journal Names Top Rheumatology Reports of 2014

May 13, 2015

Top reports chosen by Annals of Internal Medicine include several on biologics for rheumatoid arthritis and psoriatic arthritis, and mechanisms for lupus and scleroderma.

FDG-PET Useful to Resolve Doubts About GCA

May 06, 2015

A systematic review finds the technique highly sensitive and specific in diagnosing giant cell arteritis, especially useful when biopsy results are equivocal.

Cryoglobulinemia: The Basics, and Two Revelations

April 22, 2015

A review and a research study take a closer look at the small vessel disease that's generally tied to hepatitis C but may arise in autoimmune disorders. The latter finds new markers for severity.

Free For All: Rheumatology Textbook by Cush, Kavanaugh, and Stein

April 02, 2015

Three eminent rheumatologists have posted their comprehensive textbook of rheumatology online, open-access and free. They are calling it Rheumaknowledgy.

Should All Patients Get Hep B Screening Before Immunosuppressants?

March 31, 2015

About 30% of rheumatologists don't pre-test patients for hepatitis B before prescribing immunosuppressant medications. These authors offer new guidance for screening.